This document outlines 6 strategies for managing type 2 diabetes: 1) A minimal cost strategy focusing on lifestyle changes and low-cost medications like metformin and sulfonylureas. 2) A minimal weight gain strategy emphasizing metformin, acarbose, GLP-1 agonists, and DPP-4 inhibitors. 3) A hypoglycemia avoidance strategy selecting medications with low hypoglycemia risk like metformin, alpha-glucosidase inhibitors, TZDs, GLP-1 agonists, and DPP-4/SGLT-2 inhibitors. 4) A postprandial control strategy using glinides, alpha-glucosidase inhibitors, and short-acting insulin. 5) A tight gly
This document outlines 6 strategies for managing type 2 diabetes: 1) A minimal cost strategy focusing on lifestyle changes and low-cost medications like metformin and sulfonylureas. 2) A minimal weight gain strategy emphasizing metformin, acarbose, GLP-1 agonists, and DPP-4 inhibitors. 3) A hypoglycemia avoidance strategy selecting medications with low hypoglycemia risk like metformin, alpha-glucosidase inhibitors, TZDs, GLP-1 agonists, and DPP-4/SGLT-2 inhibitors. 4) A postprandial control strategy using glinides, alpha-glucosidase inhibitors, and short-acting insulin. 5) A tight gly
This document outlines 6 strategies for managing type 2 diabetes: 1) A minimal cost strategy focusing on lifestyle changes and low-cost medications like metformin and sulfonylureas. 2) A minimal weight gain strategy emphasizing metformin, acarbose, GLP-1 agonists, and DPP-4 inhibitors. 3) A hypoglycemia avoidance strategy selecting medications with low hypoglycemia risk like metformin, alpha-glucosidase inhibitors, TZDs, GLP-1 agonists, and DPP-4/SGLT-2 inhibitors. 4) A postprandial control strategy using glinides, alpha-glucosidase inhibitors, and short-acting insulin. 5) A tight gly
This document outlines 6 strategies for managing type 2 diabetes: 1) A minimal cost strategy focusing on lifestyle changes and low-cost medications like metformin and sulfonylureas. 2) A minimal weight gain strategy emphasizing metformin, acarbose, GLP-1 agonists, and DPP-4 inhibitors. 3) A hypoglycemia avoidance strategy selecting medications with low hypoglycemia risk like metformin, alpha-glucosidase inhibitors, TZDs, GLP-1 agonists, and DPP-4/SGLT-2 inhibitors. 4) A postprandial control strategy using glinides, alpha-glucosidase inhibitors, and short-acting insulin. 5) A tight gly
– minimal weight gain strategy – minimal patient effort strategy – hypoglycemia avoidance strategy – postprandial control strategy – Tight glycemic control strategy Minimal cost strategy • Lifestyle Modification • Metformin • Sulfonylurea • Insulin Minimal cost strategy • This must be seen in the context of how much is needed to treat more than 200,000 diabetic patients in Kuwait ( about 20% of the population ) >>> 50% of them cannot effort new expensive medication e.g DPP-4 , Glinids. Minimal Weight gain • Metformin • Acarbose • GLP-1 agonist • DPP-4 inhibitor • Minimizing risk of hypoglycemia is a priority. It is a matter of safety, adherence, and cost. Hypoglycemia avoidance strategy ED ADMISSION FOR HYPOGLYCEMIA DIABETID PATIENTS Drug induced hypoglycemia Hypoglycemia avoidance strategy • MFN • AGI • TZD • GLP-1 agonist • DPP-4 inhibitor • SGLT-2 inhibitor Post prandial control strategy • Glinides • AGI • Short acting insulin Tight glycemic control strategy • Insulin • Metformin • Sulfonylurea The Miracle of Insulin
Patient J.L., December 15, February 15, 1923
1922 The Most Powerful Agent We Have to Control Glucose